MedPath

Impact of vitamin D supplementation of preterm births

Phase 2
Registration Number
CTRI/2021/10/037658
Lead Sponsor
Department of Biotechnology DBT India
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Apparent healthy pregnant woman (18-40 years), before 13 weeks of gestation, willing to give informed consent, oblige to protocol regime, consume assigned supplement, and give blood samples.

Exclusion Criteria

Pregnant women with twins or multiple pregnancies, chronic morbidities, on medication or undergoing treatment, have infections such as HIV, VDRL, HBsAg, assisted pregnancy, or anticipate discontinuing or moving out of the study site.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath